Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 658Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3McCarthy Tétrault LLP

02 6Merck Canada Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Sitagliptin Phosphate

Brand Name : JANUVIA

Patent Number : 2529400

Filing Date : 2004-06-18

Strength per Unit : 100mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2024-06-18

Date Granted : 2007-10-09

blank

02

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Sitagliptin Phosphate

Brand Name : JANUVIA

Patent Number : 2450740

Filing Date : 2002-07-05

Strength per Unit : 100mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2022-07-05

Date Granted : 2006-02-14

blank

03

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Sitagliptin Phosphate

Brand Name : JANUVIA

Patent Number : 2536251

Filing Date : 2004-08-27

Strength per Unit : 100mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2024-08-27

Date Granted : 2009-08-04

blank

04

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Sitagliptin Phosphate

Brand Name : JANUVIA

Patent Number : 2536251

Filing Date : 2004-08-27

Strength per Unit : 25 mg

Dosage Form : Tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2024-08-27

Date Granted : 2009-08-04

blank

05

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Sitagliptin Phosphate

Brand Name : JANUVIA

Patent Number : 2529400

Filing Date : 2004-06-18

Strength per Unit : 25 mg

Dosage Form : Tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2024-06-18

Date Granted : 2007-10-09

blank

06

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Sitagliptin Phosphate

Brand Name : JANUVIA

Patent Number : 2450740

Filing Date : 2002-07-05

Strength per Unit : 25 mg

Dosage Form : Tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2022-07-05

Date Granted : 2006-02-14

blank

07

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Sitagliptin Phosphate

Brand Name : JANUVIA

Patent Number : 2529400

Filing Date : 2004-06-18

Strength per Unit : 50 mg

Dosage Form : Tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2024-06-18

Date Granted : 2007-10-09

blank

08

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Sitagliptin Phosphate

Brand Name : JANUVIA

Patent Number : 2536251

Filing Date : 2004-08-27

Strength per Unit : 50 mg

Dosage Form : Tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2024-08-27

Date Granted : 2009-08-04

blank

09

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Sitagliptin Phosphate

Brand Name : JANUVIA

Patent Number : 2450740

Filing Date : 2002-07-05

Strength per Unit : 50 mg

Dosage Form : Tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2022-07-05

Date Granted : 2006-02-14

blank